Gynecologic Cancer
News
Effective Second-Line Agents Identified for Anti-NMDA Receptor Encephalitis
Major Finding: A significantly greater percentage of patients with anti-NMDA receptor encephalitis recovered fully within 2 years following...
News
Adding Bevacizumab Doubles PFS in Hard-to-Treat Ovarian Cancer
Major Finding: Median progression-free survival was longer with bevacizumab and chemotherapy than with chemotherapy alone (6.7 vs.
News
New Dermoscopic Insights Gleaned for Mucosal Lesions
News
Study Fine-Tunes Link Between Endometriosis, Ovarian Cancer
News
Evidence Suggests Pregnancies Can Survive Maternal Cancer Treatment
News
ASCO: Stop Underdosing Obese Cancer Patients
Research
Spiritual Well-Being and Quality of Life of Women with Ovarian Cancer and Their Spouses
News
After Age 30, Cervical Ca Screening Intervals Extended
News
BRCA1/2 Mutations Tied to Better Ovarian Cancer Survival
Major Finding: The 5-year overall-survival rate was 36% for 2,666 non-BRCA carriers, 44% for 909 BRCA1 carriers, and 52% for 304 BRCA2 carriers....
News
Bevacizumab Effective With First-Line Treatment for Ovarian Cancer
Major Finding: The addition of 15 mg/kg bevacizumab to standard chemotherapy prolonged progression-free survival by about 4 months in women with...
News
Aflibercept Prevents Ascites Recurrence in Advanced Ovarian Cancer
Major Finding: Aflibercept extended the time until ascites recurrence required paracentesis to 55 days, compared with 23 days for placebo.Data...